Browsing by Subject "cell labeling"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Histophysiological effects of fluid resuscitation on heart, lung and brain tissues in rats with hypovolemia
    (Elsevier GmbH, 2006) Ekerbicer N.; Inan S.; Tarakci F.; Cilaker S.; Ozbek M.
    The efficacy of using colloids and crystalloids in the treatment of hypovolemia still remains controversial. An important aspect in treating hypovolemia is to re-establish normal tissue hemodynamics after fluid resuscitation. Production of nitric oxide (NO) or growth factors such as transforming growth factor beta (TGF-β) has been identified as a key mechanism in physiological and pathological processes in the different systems. This study was designed to investigate the histophysiological effects of resuscitation with different plasma substitutes on the heart, lung and brain tissues following acute blood loss in male Sprague-Dawley rats weighing 250-280 g (n=30). After anesthesia with sodium pentobarbital, the left femoral vein and artery were cannulated for the administration of volume expanders and for direct measurement of arterial pressure and heart rate. Twenty rats were bled (5 ml/10 min) and infused (5 ml/10 min) with one of four randomly selected solutions, (a) human albumin, (b) gelatin (Gelofusine), (c) dextran-70 (Macrodex); or (d) physiological saline (0.9% isotonic saline). Five control rats were bled without infusion. Tissue samples were taken and fixed in 10% formalin solution, then processed for embedding in paraffin wax. Sections were cut and stained with hematoxylin and eosin. Indirect immunohistochemical labelling was performed to reveal binding of primary antibodies against endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS) and TGF-β. Mild immunoreactivity of eNOS was observed in endothelial cells of vessels in brain, heart and lung tissues. Increased immunoreactivities of eNOS, iNOS and TGF-β were observed in the non-fluid resuscitated group in these organs; mild, moderate, moderate and strong immunoreactivities were seen in the albumin, gelatin, physiological saline and dextran-70 treated groups, respectively. Immunoreactivities of iNOS and TGF-β in the non-fluid resuscitated group were increased significantly, in comparison to the other groups, apart from the dextran-70 treated group. The results of this study show that gelatin solution and physiological saline may be of use after acute blood loss, and dextran-70 is not the preferred resuscitation fluid in the early stages of acute blood loss. It was concluded that albumin solution is the preferred fluid for resuscitation. © 2006 Elsevier GmbH. All rights reserved.
  • No Thumbnail Available
    Item
    The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia
    (2008) Akercan F.; Cirpan T.; Terek M.C.; Ozcakir H.T.; Giray G.; Sagol S.; Karadadas N.
    Objective: The study was designed to determine the protein levels of vascular endothelial growth factor (VEGF) in the placenta biopsies of patients with preeclampsia and compare with normal controls. Design: Prospective cohort study. Methods: The placental biopsies were obtained from ten patients with preeclampsia and ten patients of control group at the time of delivery. Avidin-biotin-peroxidase immunohistochemistry was then performed to identify levels of VEGF protein within the tissue and a semi-quantitative method was devised to score the amount of staining present in the sample. Two histopathologists who were blinded to the groups were asked to score each sample for the intensity of staining and the number of cells stained in a randomly selected per high-power fields of each sample. The resulting "H-score" was computed as a product of intensity and percent of cells stained. Results: The VEGF expression was significantly higher in placenta biopsies of preeclamptic patients compared to that of controls (271.2 ± 22.65 vs. 201.9 ± 12.33, P = 0.000). Conclusion: Immunostaining of VEGF is significantly higher in placenta biopsies of patients with preeclampsia. © 2007 Springer-Verlag.